HEALTH

APMA endorses Quell wearable pain device

BY Michael Johnsen

BOSTON – NeuroMetrix on Wednesday announced that it was granted the American Podiatric Medical Association Seal of Approval for its Quell Wearable Pain Relief device.
 
“The APMA Seal of Approval is awarded after a rigorous scientific review by a group of APMA member podiatrists," stated Jim Christina, APMA executive diretor. "The committee examines information about the product’s safety, quality control, and other data,” he said. “Quell received the APMA Seal of Approval which is granted to products found to be effective and promote good foot health.”
 
Quell is an easy-to-use, over-the-counter device for chronic pain relief. The wearable device utilizes NeuroMetrix's wearable intensive nerve stimulation technology to provide pain relief. In a recent clinical study, 81% of participants reported improvement with chronic pain and overall health after using Quell. 
 
Quell is available through select healthcare professionals and retailers.
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

LifeScan syncs diabetes management app to Apple Health

BY Michael Johnsen

CHESTERBROOK, Pa. — The Johnson & Johnson Diabetes Solutions Companies announced Thursday that people with diabetes using LifeScan's OneTouch Reveal mobile management app can now view their blood sugar readings directly in the Health app on their iPhone and choose to privately and securely share that data with their healthcare team.  
 
OneTouch Verio Sync meter users can wirelessly sync their data to the OneTouch Reveal mobile app for access across multiple devices. Now, this information can be synced with the Apple Health app and shared with healthcare providers.
 
“For the nearly 400 million people worldwide living with diabetes, management needs to be approached holistically — looking not only at blood glucose levels, but also insights gleaned from how factors like diet and exercise, as well as insulin and other medications impact individual treatment regimens,” stated Brian Levy, LifeScan chief medical officer. “The only way this can be done successfully is by allowing patients to gather, combine and share their data in ways that are easier and more intuitive for them.”
 
The company also announced that in honor of World Diabetes Day on Nov. 14, it will donate 1.3 Million blood glucose monitoring test strips in support of the Life for a Child program — the International Diabetes Federation's ongoing effort to provide needed diabetes supplies to children worldwide. 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Zicam launches zinc-free nasal swabs

BY Michael Johnsen

BRIDGEWATER, N.J. — Matrixx Initiatives on Thursday announced the release of the reformulated Zicam Cold Remedy Nasal Swabs. Due to consumer demand, Zicam has brought back the swab applicator to deliver the new plant-based formula, the company reported.
 
“At Zicam, we're dedicated to finding ways to help people feel better faster,” said M'lou Walker, CEO of Matrixx Initiatives. “Our new, clinically proven Cold Remedy Nasal Swabs were developed to help shorten colds so that users can step up and seize the day.”
 
According to Matrixx, the new swabs have been clinically proven to shorten the duration of a cold when taken at the first sign. They also lessen the severity of common cold symptoms such as nasal congestion, watery eyes, runny nose, sneezing and dry, scratchy throat, the company said. 
 
The new formula is homeopathic, zinc-free and provides cooling menthol and eucalyptus to help soothe the nasal passages upon application.
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?